SYSMHC00079_DPrep1 | 4 | Human | HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401 | ||
SYSMHC00079_DPrep2 | 4 | Human | HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401 | ||
SYSMHC00079_DPrep3 | 4 | Human | HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401 | ||
SYSMHC00079_DPrep4 | 16 | Human | HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401 | ||
SYSMHC00079_DPrep5 | 16 | Human | HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401 | ||
SYSMHC00079_DQrep1 | 19 | Human | HLA-DQA10505-DQB10301 | ||
SYSMHC00079_DQrep2 | 6 | Human | HLA-DQA10505-DQB10301 | ||
SYSMHC00079_DQrep3 | 4 | Human | HLA-DQA10505-DQB10301 | ||
SYSMHC00079_DQrep4 | 4 | Human | HLA-DQA10505-DQB10301 | ||
SYSMHC00079_DQrep5 | 6 | Human | HLA-DQA10505-DQB10301 | ||
SYSMHC00079_DQrep6 | 16 | Human | HLA-DQA10505-DQB10301 | ||
SYSMHC00079_DRrep1 | 4 | Human | DRB1_1201,DRB3_0202 | ||
SYSMHC00079_DRrep2 | 8 | Human | DRB1_1201,DRB3_0202 | ||
SYSMHC00079_DRrep3 | 4 | Human | DRB1_1201,DRB3_0202 | ||
SYSMHC00079_DRrep4 | 16 | Human | DRB1_1201,DRB3_0202 | ||
SYSMHC00079_DRrep5 | 15 | Human | DRB1_1201,DRB3_0202 | ||
SYSMHC00079_DRrep6 | 15 | Human | DRB1_1201,DRB3_0202 | ||
SYSMHC00079_DRrep7 | 31 | Human | DRB1_1201,DRB3_0202 |
SYSMHC00079 | SYSMHC00079_DQrep5 | DQrep5_A1112.wiff | In vitro | suspension | EBV transformed | class II | PXD025877 | native | Immunoaffinity | SPV-L3 | Triple-TOF 5600 | no | DDA | CID-QTOF | 90 | 300 nL/min | 1 | |||||||
SYSMHC00079 | SYSMHC00079_DQrep5 | DQrep5_A13-B15.wiff | In vitro | suspension | EBV transformed | class II | PXD025877 | native | Immunoaffinity | SPV-L3 | Triple-TOF 5600 | no | DDA | CID-QTOF | 90 | 300 nL/min | 2 | |||||||
SYSMHC00079 | SYSMHC00079_DQrep5 | DQrep5_A579ex.wiff | In vitro | suspension | EBV transformed | class II | PXD025877 | native | Immunoaffinity | SPV-L3 | Triple-TOF 5600 | no | DDA | CID-QTOF | 90 | 300 nL/min | 3 | |||||||
SYSMHC00079 | SYSMHC00079_DQrep5 | DQrep5_A579.wiff | In vitro | suspension | EBV transformed | class II | PXD025877 | native | Immunoaffinity | SPV-L3 | Triple-TOF 5600 | no | DDA | CID-QTOF | 90 | 300 nL/min | 4 | |||||||
SYSMHC00079 | SYSMHC00079_DQrep5 | DQrep5_A6810ex.wiff | In vitro | suspension | EBV transformed | class II | PXD025877 | native | Immunoaffinity | SPV-L3 | Triple-TOF 5600 | no | DDA | CID-QTOF | 90 | 300 nL/min | 5 | |||||||
SYSMHC00079 | SYSMHC00079_DQrep5 | DQrep5_A6810.wiff | In vitro | suspension | EBV transformed | class II | PXD025877 | native | Immunoaffinity | SPV-L3 | Triple-TOF 5600 | no | DDA | CID-QTOF | 90 | 300 nL/min | 6 |